Organogenesis Holdings Inc. (ORGO)

Pharmaceutical Preparations

Latest Price

$1.46

TTM P/E

Normalized P/E

Div Yield

Book Value

1.16

P/B Ratio

1.26

Valuation metrics

EPS: $0.15

Book value / share: $2.36

Formula: √(22.5 × EPS × BVPS)

Graham Number

$2.82

+93% upside

Norm. op. income: $22M (median of 7yr)

Tax rate: 22%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$1.58

+8% upside

Base FCF: $7M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$0.43

70% downside

EPS: $0.15

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$2.25

+54% upside

50.7% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
MORGAN STANLEY	11.72M	$28.0M	9.11%	+104.8K	2026-06-30
Soleus Capital Management, L.P.	10.14M	$24.0M	7.88%	+55.0K	2026-06-30
BlackRock, Inc.	7.25M	$17.0M	5.63%	+2.35M	2026-06-30
DIMENSIONAL FUND ADVISORS LP	3.05M	$7.0M	2.37%	+159.3K	2026-06-30
AQR CAPITAL MANAGEMENT LLC	3.01M	$7.0M	2.34%	+2.13M	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	2.91M	$7.0M	2.26%	+5.1K	2026-06-30
D. E. Shaw & Co., Inc.	2.89M	$7.0M	2.24%	+590.3K	2026-06-30
Assenagon Asset Management S.A.	1.97M	$4.0M	1.53%	--	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	1.94M	$4.0M	1.50%	+151.6K	2026-06-30
DEUTSCHE BANK AG\	1.71M	$4.0M	1.33%	+505	2026-06-30